4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-004113
Chief Scientific Officer sold 11,100 shares at an average $28.77 ($319,329)
- Chief Scientific Officer acquired 11,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-15 | Option exercise | +3,700 | $6.32 | $23,384 | 74,379 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-15 | Sale | −3,700 | $29.52 | $109,224 | 70,679 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-16 | Option exercise | +3,700 | $6.32 | $23,384 | 74,379 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-16 | Sale | −1,100 | $27.80 | $30,580 | 73,279 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-16 | Sale | −1,300 | $28.98 | $37,674 | 71,979 | D: show line 5 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-16 | Sale | −1,300 | $29.54 | $38,402 | 70,679 | D: show line 6 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-17 | Option exercise | +3,700 | $6.32 | $23,384 | 74,379 | D: show line 7 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-17 | Sale | −1,300 | $27.33 | $35,529 | 73,079 | D: show line 8 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-17 | Sale | −2,400 | $28.30 | $67,920 | 70,679 | D: show line 9 in the form |
| Open-market sales · 11,100 sh · avg $28.77 · $319,329 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-15 | Option exercise · Stock Option (Right to Buy) | −3,700 | 596,300 | D: show line 10 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-16 | Option exercise · Stock Option (Right to Buy) | −3,700 | 592,600 | D: show line 11 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2020-01-17 | Option exercise · Stock Option (Right to Buy) | −3,700 | 588,900 | D: show line 12 in the form |
Loading xslF345X03/doc4.xml…